TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07503561: A Trial to Evaluate the Safety, Tolerability and Efficacy of AIC263029 in Kidney Transplant Recipients With BKV Infection

Sponsor: AiCuris Anti-infective Cures AG · Phase: PHASE2 · Area: INFECTIOUS_VACCINE · Target Enrollment: 24 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$970,200

Rescue Site Savings

+$646,800

Unlock Full NCT07503561 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07503561 Rescue Dossier →